mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerabilityNiklas Gremke, Thorsten Stiewe|Nature Communications|2020Cited by 171
Challenging ChatGPT 3.5 in Senology—An Assessment of Concordance with Breast Cancer Tumor Board Decision MakingSebastian Griewing, Jelena Boekhoff, Michael Lingenfelder et al.|Journal of Personalized Medicine|2023Cited by 70
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugsNiklas Gremke, Thorsten Stiewe, Mattea Reinisch et al.|Signal Transduction and Targeted Therapy|2025Cited by 19
Positive association between body height and breast cancer prevalence: a retrospective study with 135,741 women in GermanyNiklas Gremke, Karel Kostev, Sebastian Griewing et al.|Breast Cancer Research and Treatment|2022Cited by 19
Proof-of-concept study of a small language model chatbot for breast cancer decision support – a transparent, source-controlled, explainable and data-secure approachSebastian Griewing, Sebastian Kühn, Stefan Lukac et al.|Journal of Cancer Research and Clinical Oncology|2024Cited by 16